Benign neoplasm: Ciliary body

CD2_BENIGN_CILIARY

stomach neoplasm: A benign or malignant neoplasm involving the stomach.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D31.4& Cause of death: ICD-10 — D31.4& 2 out of 7 registries used, show all original rules.	128
4. Check minimum number of events None	128
5. Include endpoints None	128
6. Filter based on genotype QC (FinnGen only)	115

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D31
Name in latin: Neoplasma benignum corporis ciliaris

NAME	CD2_BENIGN_CILIARY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D314
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D314
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Ciliary body based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	562	332	227
Only index persons	535	325	210
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	61.29	61.05	61.90
Only index persons	61.53	61.28	61.92

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	115	65	50
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	64.48	60.69	69.39

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
117: Matched controls
1170

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D31.4

ICD-10 Finland

Benign neoplasm: Ciliary body

+∞

168.9

117

XCD10

NOMESCO Finland

Electrophysiological examination of eye

53.6

77.9

CH2S4

NOMESCO Finland

Photography of iris

+∞

27.1

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

43.3

26.3

XCK10

NOMESCO Finland

Photography of fundus of eye

8.4

24.7

Z3229

NOMESCO Finland

Other healthcare associate professional

7.1

17.0

Z01.0

ICD-10 Finland

Examination of eyes and vision

4.7

14.3

147

CH3S4

NOMESCO Finland

Photography of iridocorneal angle

+∞

11.6

CD2S4

NOMESCO Finland

Photography of eye

48.3

11.2

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

66.2

10.8

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

6.1

10.0

C69.40

ICD-10 Finland

Malignant tumor of ciliary body without histology

+∞

9.5

H21.3

ICD-10 Finland

Cyst of iris, ciliary body and anterior chamber

+∞

9.5

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

26.5

9.1

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

73.7

6.5

H21.8

ICD-10 Finland

Other specified disorders of iris and ciliary body

73.7

6.5

H21.9

ICD-10 Finland

Disorder of iris and ciliary body, unspecified

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(42870588) Differential panel, method unspecified - Blood

347

2.03

3.45

5.1

5.8

—

(3045142) Bone marrow Pathology biopsy report

5.65

2.91

1.0

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

105

2.09

2.11

2.0

3.0

69.56

73.62

e9/l

0.24

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

3.89

1.96

1.5

1.8

30.33

31.63

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

3.27

1.68

1.2

1.5

—

(3021589) Normoblasts [#/volume] in Blood

468

1.58

1.63

14.0

12.5

0.00

e9/l

0.84

387

(40768797) Stomach Pathology biopsy report

167

1.72

1.51

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

783

1.65

1.45

4.4

4.6

14.80

14.75

pmol/l

0.06

705

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

3.22

1.45

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

108

999

2.05

1.44

17.5

16.9

20.03

23.44

mg/l

0.49

835

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

133

0.42

1.39

2.7

5.1

2.63

9.50

ug/l

—

107

(3002256) Pathology report gross observation

130

1.75

1.38

1.4

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

3.02

1.37

1.6

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

226

1.57

1.29

5.5

3.7

64.44

244.58

ng/l

0.69

183

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

176

1.61

1.24

3.2

3.0

1.45

2.23

e6/l

0.32

(3048689) Calprotectin [Mass/mass] in Stool

118

1.73

1.24

3.2

2.3

92.36

188.10

ug/g

1.02

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

222

1.54

1.17

2.1

1.9

515.96

439.43

pmol/l

0.89

181

(40760888) Immunoglobulin light chains.free panel - Serum

2.56

1.16

5.4

4.2

—

(3037121) Protein [Mass/volume] in Urine

0.00

1.16

0.0

3.5

—

166.73

—

(40761536) Microorganisms panel - Urine sediment

1.76

1.10

4.1

3.6

—

(1616796) Gas panel - Central venous blood

2.44

1.10

2.4

3.2

—

(40761511) CBC panel - Blood by Automated count

109

1029

1.87

1.01

16.3

15.2

—

(21494755) Public health laboratory ask at order entry panel

1.74

0.99

1.2

1.5

—

(3018418) pH of Serum or Plasma

349

1.42

0.99

5.4

4.3

7.40

0.12

242

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

853

1.52

0.99

25.7

21.2

13.96

13.69

0.80

847

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

2.00

0.99

1.1

1.2

1.57

1.60

g/l

—

(40768804) Tissue Pathology biopsy report

426

1.40

0.97

2.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

106

990

1.75

0.96

20.9

16.6

77.62

78.40

ml/min/173m2

0.17

100

933

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

544

1.39

0.96

6.9

7.6

1.21

mmol/l

0.25

466

(40758558) Short blood count panel - Blood

323

1.41

0.96

7.1

7.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.95

0.96

1.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.95

0.96

1.0

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.95

0.96

1.3

1.2

0.77

0.88

g/l

—

(3030467) Casts [#/volume] in Urine by Automated count

314

1.42

0.95

3.9

3.1

0.37

0.42

e6/l

0.07

232

(3014051) Protein [Presence] in Urine by Test strip

306

1.41

0.93

2.7

2.8

—

0.29

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.69

0.92

5.9

4.5

1.22

mmol/l

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

353

1.40

0.92

3.8

3.4

884.95

993.29

ng/l

0.20

296

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

498

1.37

0.91

5.2

6.7

1.22

1.21

mmol/l

0.37

453

(3013826) Glucose [Moles/volume] in Serum or Plasma

648

1.39

0.91

3.5

5.3

6.67

6.79

mmol/l

0.16

620

(3032080) INR in Blood by Coagulation assay

528

1.37

0.90

20.0

13.4

1.27

1.25

inr

0.13

434

(3019150) Specific gravity of Urine by Refractometry

245

0.64

0.89

2.5

4.0

1.01

1.02

kg/l

0.31

169

(3028626) Oxygen [Partial pressure] in Capillary blood

1.98

0.85

1.8

8.77

8.04

kpa

—

(1761868) Lipid panel - Serum or Plasma

395

1.36

0.85

3.9

3.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.92

0.83

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

101

941

1.54

0.81

5.7

5.6

1.86

1.92

mu/l

0.20

856

(3013115) Eosinophils [#/volume] in Blood

554

1.34

0.81

6.6

6.5

0.19

0.20

e9/l

0.20

485

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.78

0.0

5.0

—

29.36

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

2.22

0.77

1.0

2.6

6.86

9.07

pmol/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

117

1.53

0.77

2.9

3.4

—

(3022145) Colonoscopy Study observation

126

1.51

0.76

1.1

1.4

—

(3008898) HLA-B27 [Presence]

1.89

0.75

1.0

1.2

—

(3042936) Bacteria identified in Isolate by Culture

168

0.62

0.74

1.5

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

500

0.75

0.74

2.5

2.7

—

estimate

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

784

1.37

0.73

4.2

4.5

9.58

12.07

mm/h

0.82

724

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

570

1.32

0.72

2.9

—

(3021901) Oxygen saturation in Capillary blood

1.96

0.71

1.6

2.0

93.98

90.23

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.67

0.68

1.4

2.0

—

(3001604) Monocytes [#/volume] in Blood

534

1.30

0.67

5.7

6.3

0.64

0.59

e9/l

0.56

459

(4094501) Cardiovascular stress test using bicycle ergometer

1.76

0.64

1.0

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.64

0.64

1.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

250

0.71

0.62

2.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

459

1.28

0.62

1.9

2.0

1.18

1.36

mmol/l

0.99

384

(3006315) Basophils [#/volume] in Blood

539

1.28

0.61

5.7

6.3

0.05

0.04

e9/l

1.17

462

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.60

0.0

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.60

0.0

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.59

0.0

1.6

—

222.29

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

103

978

1.44

0.58

6.9

7.0

38.81

39.71

mmol/mol

0.82

922

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.70

0.57

1.0

1.2

—

(3009343) pH of Capillary blood

1.54

0.55

1.9

2.7

7.43

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

189

1.34

0.55

3.6

3.0

0.78

0.90

e6/l

—

102

(3000991) Gas panel - Venous blood

0.60

0.55

3.0

9.0

—

(3025941) Bacteria identified in Stool by Culture

1.49

0.54

1.0

1.3

—

(3019198) Lymphocytes [#/volume] in Blood

547

1.24

0.51

5.7

6.3

2.42

1.86

e9/l

0.30

487

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

391

1.25

0.50

3.4

3.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.55

0.49

2.3

2.5

—

(1002224) Polysomnography panel

1.52

0.48

1.0

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.59

0.47

2.0

2.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

356

1.23

0.45

4.9

5.3

1.53

1.94

ug/l

1.00

316

(3031040) Bacteria [#/volume] in Urine by Automated count

683

1.23

0.45

4.3

4.4

—

336.33

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.59

0.43

1.6

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.41

0.42

2.3

3.9

4.38

4.53

pmol/l

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.43

0.42

2.4

2.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

530.67

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.41

0.0

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.41

0.0

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.41

0.0

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

262.89

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.41

0.0

1.1

—

34.12

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

0.00

0.41

0.0

1.9

—

29.33

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

0.00

0.41

0.0

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.41

0.0

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.41

0.0

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.49

0.41

1.6

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

198

1.27

0.40

1.1

1.4

98.92

30.82

iu/ml

—

(40768800) Prostate Pathology biopsy report

0.00

0.40

0.0

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.45

0.40

2.0

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

135

1.30

0.38

2.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

439

0.83

0.37

3.6

3.8

0.00

0.03

estimate

0.50

(40761535) Cells panel - Urine sediment

0.63

0.37

3.6

3.9

—

(3019060) Gas panel - Arterial blood

0.62

0.37

3.4

4.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1.49

0.36

1.7

2.6

1.03

1.55

mg/l

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.45

0.36

2.2

2.5

—

(3002582) Erythrocytes [#/volume] in Urine

365

1.19

0.34

4.0

3.3

14.31

211.24

e6/l

0.58

282

(36660697) Celiac disease serology panel - Serum

0.66

0.34

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.37

0.32

1.0

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

452

0.86

0.29

4.2

4.1

28.81

156.85

ng/l

0.52

327

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.29

0.28

2.0

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

104

1.28

0.28

1.5

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

348

0.85

0.28

2.2

2.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.23

0.27

1.5

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

600

1.15

0.27

12.1

10.4

3.98

4.09

e9/l

0.18

521

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

142

1.23

0.26

2.1

1.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

103

1002

1.23

0.24

5.7

5.6

4.53

4.62

mmol/l

0.42

926

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1.23

0.22

2.4

2.1

22.42

25.77

mmol/l

—

(3020682) Albumin/Creatinine [Ratio] in Urine

383

0.88

0.22

3.9

4.3

3.08

7.48

mg/mmol

1.35

227

(3029937) Albumin [Presence] in Urine by Test strip

311

0.87

0.21

3.4

4.2

0.00

0.02

estimate

0.50

104

(3019309) Folate [Moles/volume] in Red Blood Cells

193

1.17

0.21

2.6

1.7

1100.54

1261.15

nmol/l

0.29

142

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.21

0.0

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.7

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

0.21

0.0

1.5

—

(3004451) EKG impression Narrative

0.00

0.21

0.0

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.21

0.0

4.3

—

0.90

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.21

0.0

2.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.21

0.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.21

0.0

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.8

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

114

0.77

0.21

1.2

1.9

1.14

1.51

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

115

0.76

0.21

4.6

7.9

—

(40768441) Liver Pathology biopsy report

0.00

0.21

0.0

1.2

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.0

—

(4268621) Lupus anticoagulant assay

0.00

0.21

0.0

1.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.21

0.0

4.9

—

877.85

—

(3018095) Leukocytes [#/volume] in Urine

408

1.13

0.20

4.8

3.9

16.63

52.78

e6/l

1.09

291

(40768443) Skin Pathology biopsy report

1.26

0.20

1.2

1.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.2

—

14.01

—

(3035350) Ketones [Presence] in Urine by Test strip

568

1.12

0.19

3.4

3.9

0.00

estimate

-0.00

113

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

163

0.84

0.18

1.4

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

0.75

0.17

2.8

3.9

144.40

126.88

g/l

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

0.76

0.17

3.8

3.0

24.20

24.49

mmol/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

102

998

1.17

0.17

5.6

5.5

1.47

1.48

mmol/l

0.11

910

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

104

1019

1.19

0.17

6.3

2.66

2.67

mmol/l

0.03

938

(3014576) Chloride [Moles/volume] in Serum or Plasma

149

1.16

0.17

3.0

7.9

105.18

104.04

mmol/l

0.63

149

(4035726) Immunohistochemistry procedure

111

1.19

0.16

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.14

0.16

1.1

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

315

1.11

0.16

1.6

1.7

21.01

20.97

nmol/l

0.01

255

(3028026) IgM [Mass/volume] in Serum or Plasma

1.15

0.15

1.2

1.7

0.80

1.15

g/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

129

0.84

0.15

6.4

5.0

33.80

32.05

—

(3009261) Glucose [Presence] in Urine by Test strip

573

1.10

0.15

3.4

3.9

0.00

estimate

-0.00

102

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

0.80

0.15

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

564

1.09

0.14

3.4

3.9

0.00

estimate

-0.00

111

(3000492) Spirometry study

103

1.18

0.14

1.3

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1.19

0.13

2.6

2.0

9.35

9.94

g/l

0.23

(3017143) Hepatitis C virus Ab [Presence] in Serum

116

0.85

0.12

1.2

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

101

992

1.13

0.12

5.5

5.4

5.82

5.99

mmol/l

0.90

914

(3026008) Bacteria identified in Urine by Culture

320

0.92

0.11

2.9

2.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

146

0.88

0.11

1.3

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

963

1.11

0.10

4.6

1.16

1.28

mmol/l

1.22

876

(3009508) Creatinine [Moles/volume] in Urine

389

0.93

0.10

3.1

3.3

7.89

7.74

mmol/l

0.07

314

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

469

0.93

0.09

2.2

94.31

95.71

pmol/l

0.04

228

(4024509) Urine culture

1.12

0.09

2.0

1.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

185

1.10

0.09

2.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

256

0.92

0.08

1.0

1.3

0.44

1.37

u/ml

—

(3000330) Specific gravity of Urine by Test strip

1.06

0.08

3.5

1.02

ratio

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

245

1.08

0.08

1.8

1.72

1.77

mg/l

0.02

211

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

143

0.90

0.08

1.3

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.09

0.07

3.8

7.2

25.14

25.26

mmol/l

—

(3012516) Albumin [Mass/volume] in Urine

375

0.94

0.07

3.1

3.5

21.48

55.77

mg/l

1.74

238

(3020779) Urea [Moles/volume] in Serum or Plasma

101

0.88

0.06

2.9

7.5

9.62

9.70

mmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

100

0.89

0.06

1.8

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

249

0.95

0.03

7.3

5.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

103

1.08

0.02

2.7

7.8

0.96

1.17

mmol/l

1.04

103

(3019977) pH of Arterial blood

137

0.94

0.01

2.9

8.6

7.42

7.41

—

(3000494) Fungus identified in Specimen by Culture

137

0.94

0.01

1.3

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

288

1.01

0.00

3.3

4.5

24.44

23.58

0.08

138

(3041096) Erythrocytes [Presence] in Urine by Automated

332

0.99

0.00

3.7

3.0

0.00

estimate

-0.00

(3015736) pH of Urine

448

1.01

0.00

3.0

3.6

6.02

6.16

0.45

258

(3007853) Bacteria identified in Skin by Aerobe culture

117

1.03

0.00

1.2

1.8

—

(3003694) ABO and Rh group [Type] in Blood

289

1.00

0.00

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

217

1.02

0.00

3.1

0.69

0.77

ug/l

—

143

(3007164) IgA [Mass/volume] in Serum or Plasma

234

0.98

0.00

1.2

1.5

2.06

2.92

g/l

1.08

133

(3023368) Bacteria identified in Blood by Culture

296

1.02

0.00

5.1

4.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

169

1.01

0.00

1.3

1.9

—

(3037522) Nuclear Ab [Titer] in Serum

151

0.99

0.00

1.1

1.4

—

556.47

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.8

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.00

0.0

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.0

1.6

—

(4198724) Urine methamphetamine measurement

0.00

0.0

1.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.0

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

0.00

0.0

52.8

—

101.80

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

0.62

—

(4211845) Urine protein measurement

0.00

0.0

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.0

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

0.0

1.6

—

(3013727) Leukocytes other/Leukocytes in Blood

0.00

0.0

5.2

—

58.20

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

0.00

0.0

3.0

—

25.80

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

40.64

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.6

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

67.50

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

2.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.97

-0.00

1.1

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

0.00

-0.00

0.0

2.1

—

11.86

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

2.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(3036603) Volume of Urine

0.00

-0.00

0.0

1.3

—

1531.67

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

-0.00

0.0

3.3

—

5.46

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

75.38

—

(3020491) Glucose [Moles/volume] in Blood

0.00

-0.00

0.0

2.1

—

7.06

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

-0.00

0.0

3.0

—

23.67

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(3022313) Gas panel - Capillary blood

1.02

-0.00

2.4

2.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

233.00

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

50.11

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

20.4

—

720.75

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

10.90

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

3.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

-0.00

0.0

2.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3035880) pH of Pleural fluid

0.00

-0.00

0.0

1.2

—

7.34

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

9.6

—

16.42

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_CILIARY and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_CILIARY.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_CILIARY – Benign neoplasm: Ciliary body

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Ciliary body

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints